Close

Magellan Health (MGLN) Tops Q3 EPS by 72c

November 9, 2016 6:37 AM EST

Magellan Health (NASDAQ: MGLN) reported Q3 EPS of $1.39, $0.72 better than the analyst estimate of $0.67. Revenue for the quarter came in at $1.29 billion versus the consensus estimate of $1.22 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings